Joost DeJongh

3PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsPlanning and decision makingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 17, 2025
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic-pharmacodynamic model.

Joost DeJongh, Elaine Cadogan, Michael Davies

|May 08, 2024
Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development.

Martijn van Noort, Martijn Ruppert, Joost DeJongh

|Feb 04, 2021
A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy.

Joost DeJongh, Maurice Ahsman, Nelleke Snelder

Pageof 1